Aug 8, 2026 · 1h 1m

Biohackers challenge the stigma around performance enhancement

Episode #151: My Special Guest Appearance on the HUMAN UPGRADE Podcast with Dave Asprey

The conversation tests where informed self-experimentation, medical autonomy, and personalized health choices meet real risks and uncertain evidence.

3 key takeaways

1Dave Asprey and Dylan Gemelli argue that performance-enhancing tools deserve harm-reduction scrutiny rather than blanket moral judgment.
2Their nutrition discussion favors systematic personal experimentation over universal diets, linking food choices to energy, hormones, and cardiovascular health.
3Testosterone replacement, peptides, and research chemicals expose the tension between individual autonomy, medical oversight, and incomplete regulatory certainty.

Don't miss

Dylan recounts discovering coronary calcium and elevated Lp(a), then describes experimenting with several interventions while tracking plaque findings and heart function.

The brief

Dave Asprey and Dylan Gemelli open by rejecting the idea that using technology or compounds to improve health automatically counts as cheating, setting up a debate over autonomy and risk.

They examine the regulatory gray zone around peptides, SARMs, and nootropics, asking whether limited approval or controversial use should determine how seriously a health strategy is taken.

The conversation moves from performance drugs and nicotine to extreme leanness, restrictive diets, and personalized nutrition, with both hosts favoring measured experimentation over universal rules.

A standout thread follows Dylan’s account of coronary calcium and elevated Lp(a), alongside reported changes in plaque findings and heart function after trying several interventions.

Testosterone replacement, Kyzatrex, peptides, sunlight, and exercise broaden the argument: informed medical autonomy may be valuable, but every intervention carries tradeoffs that demand scrutiny.

Featuring